BUY Zydus Lifesciences Limited — Chandan Taparia, Motilal Oswal

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))25 Sept 2026via Business Today

Entry₹1,203.5Inferred
Target₹1,250
Stop lossNot given
CMP₹1,197.5Just now
Active-0.50%+4.38%upside left 14d left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Sept, 2:20 pm IST
4 supporting1 neutral0 opposing
Supports the BUY call (4)

MACD above its signal line — bullish momentum

Technicals · macd·25 Sept · today

4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·25 Sept · today

Bernstein bets on this drugmaker for 28% upside citing a key value driver for the future

NewsCnbc-Tv18·18 Sept · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·12 Aug · 1mo ago

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.